These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3242468)

  • 1. Positive response to edrophonium in death adder (Acanthophis antarcticus) envenomation.
    Hudson BJ
    Aust N Z J Med; 1988 Oct; 18(6):792-4. PubMed ID: 3242468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinesterases as antidotes to envenomation of rats by the death adder (Acanthophis antarcticus).
    Flachsenberger W; Mirtschin P
    Toxicon; 1994 Jan; 32(1):35-9. PubMed ID: 9237335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of neurotoxicity with anticholinesterase therapy in death-adder envenomation.
    Currie B; Fitzmaurice M; Oakley J
    Med J Aust; 1988 May; 148(10):522-5. PubMed ID: 3367819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidemiological study of snake bite envenomation in Papua New Guinea.
    Currie BJ; Sutherland SK; Hudson BJ; Smith AM
    Med J Aust; 1991 Feb; 154(4):266-8. PubMed ID: 1994203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edrophonium test in myasthenia: quantitative oculography.
    Williams IM; Dickinson P; Sum AC
    Clin Exp Neurol; 1986; 22():1-12. PubMed ID: 3581498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human anti-snake venom IgG antibodies in a previously bitten snake-handler, but no protection against local envenoming.
    Isbister GK; Halkidis L; O'Leary MA; Whitaker R; Cullen P; Mulcahy R; Bonnin R; Brown SG
    Toxicon; 2010; 55(2-3):646-9. PubMed ID: 19647759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four cases of snake envenomation responsive to death adder antivenom.
    Swindells KL; Russell NJ; Angles JM; Foster SF
    Aust Vet J; 2006; 84(1-2):22-9. PubMed ID: 16498830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The death adder (Acanthophis antarcticus): the effect of the bite and its treatment.
    Campbell CH
    Med J Aust; 1966 Nov; 2(20):922-5. PubMed ID: 4224323
    [No Abstract]   [Full Text] [Related]  

  • 9. Detectable voice change with the edrophonium test in laryngeal myasthenia gravis.
    Tsunoda K; Fujimaki Y; Morita Y
    J Int Med Res; 2017 Oct; 45(5):1466-1469. PubMed ID: 28379106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study.
    Watt G; Theakston RD; Hayes CG; Yambao ML; Sangalang R; Ranoa CP; Alquizalas E; Warrell DA
    N Engl J Med; 1986 Dec; 315(23):1444-8. PubMed ID: 3537783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dropped head with positive intravenous edrophonium, progressing to myasthenia gravis.
    Sawa N; Kataoka H; Eura N; Ueno S
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23376659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The office Tensilon test for ocular myasthenia gravis.
    Daroff RB
    Arch Neurol; 1986 Aug; 43(8):843-4. PubMed ID: 3729767
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of snake venoms and their neurotoxins on the nervous system of man and animals.
    Campbell CH
    Contemp Neurol Ser; 1975; 12():259-93. PubMed ID: 124647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity, anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death adders (Acanthophis sp.) in southern Papua New Guinea.
    Lalloo DG; Trevett AJ; Black J; Mapao J; Saweri A; Naraqi S; Owens D; Kamiguti AS; Hutton RA; Theakston RD; Warrell DA
    QJM; 1996 Jan; 89(1):25-35. PubMed ID: 8730340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the biochemical and biological variations from the venom of the death adder species (Acanthophis antarcticus, A. praelongus and A. pyrrhus).
    van der Weyden L; Hains PG; Broady KW
    Toxicon; 2000 Dec; 38(12):1703-13. PubMed ID: 10858511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new curare test for the diagnosis of myasthenia gravis.
    Foldes FF; Klonymus DH; Maisel W; Osserman KE
    JAMA; 1968 Feb; 203(9):649-53. PubMed ID: 5694171
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and pharmacological characterization of a phospholipase A2 myotoxin from the venom of the Irian Jayan death adder (Acanthophis rugosus).
    Wickramaratna JC; Fry BG; Aguilar MI; Kini RM; Hodgson WC
    Br J Pharmacol; 2003 Jan; 138(2):333-42. PubMed ID: 12540524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species-dependent variations in the in vitro myotoxicity of death adder (Acanthophis) venoms.
    Wickramaratna JC; Fry BG; Hodgson WC
    Toxicol Sci; 2003 Aug; 74(2):352-60. PubMed ID: 12773755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What to do in case of acquired ptosis].
    Guépratte N; Lebuisson DA
    J Fr Ophtalmol; 2002 Mar; 25(3):341-3. PubMed ID: 11941263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.